Revenue: EUR 2.4 billion, up 1.7% year-on-year. EBITDA: EUR 329 million, slightly down from the previous year. Specialty Materials EBITDA: EUR 331 million, showing resilience with a 3% decline. Adhesive Solutions EBITDA: Close to EUR 100 million, with a margin of 13.8%. Advanced Materials EBITDA: Increased by 7%, with a margin improvement of 100 basis points to 19.5%. Coating Solutions EBITDA: EUR 58 million, impacted by low cycle conditions. Recurring EBIT: EUR 160 million, with a margin of 6.7%. Adjusted Net Income: EUR 99 million, equating to EUR 31 per share. Recurring Cash Flow: Minus EUR 138 million, influenced by seasonal working capital changes. Net Debt: Just over EUR 3.4 billion, with a net debt to EBITDA ratio of 2.3 times. Capital Expenditure: EUR 9 million in Q1, with annual guidance around EUR 650 million. Warning! GuruFocus has detected 6 Warning Signs with ARKAF. Release Date: May 07, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Arkema SA (ARKAF) demonstrated resilience in its Specialty Materials segment, which represents 93% of total sales, with only a 3% decline in EBITDA despite challenging market conditions. The Advanced Materials segment saw a 7% increase in EBITDA, driven by strong growth in high-performance polymers, particularly in Asia. The integration of Dow Adhesives is progressing well, with expectations of significant development and synergies over the next five years. Arkema SA (ARKAF) is making progress on major projects, including the ramp-up of the 1233zd unit in the US and the greenfield polyamide 11 plant in Singapore, which is expected to exceed breakeven by summer. A long-term agreement with ENGIE for biomethane supply will cover 85% of Bostik's gas consumption in France, contributing to Arkema SA (ARKAF)'s CO2 reduction goals. Negative Points The macroeconomic environment remains difficult, with volatility and uncertainty, particularly due to trade tariffs affecting customer demand in the US. Intermediates, which account for 7% of sales, experienced a significant decline due to weak refrigerant gases, expected to remain weak into the second quarter. The Adhesives segment faced weak demand in Europe and North America, impacting EBITDA margins, which were diluted by the integration of Dow Adhesives. Coating Solutions continued to face low market conditions, particularly in upstream acrylics, affecting segment performance. The company anticipates continued pressure from unfavorable foreign exchange rates and the indirect impact of tariffs on global demand. Story Continues Q & A Highlights Q: Are we now at a point where PIAM is delivering its next phase of growth, and can we expect consistent growth from PIAM going forward? A: Thierry Le Henaff, CEO: PIAM is indeed growing, especially in electronics, and we expect this growth to continue. While the 70% year-on-year growth in Q1 is significant, we anticipate continued growth in the coming quarters and years, although not necessarily at the same rate as Q1. Q: Did you see any pre-buying from customers in Q1 due to tariffs, and how does this affect your guidance for 2025? A: Thierry Le Henaff, CEO: There might have been some pre-buying in Asia, but overall, we see a good trend in Asia. For 2025, we expect a rebound in the second half, driven by low stock levels and project ramp-ups, despite a weak first half. Q: What is driving your positive pricing in high-performance polymers, and can you specify which polymers and applications are contributing? A: Thierry Le Henaff, CEO: The positive pricing is driven by good volume and new business development, particularly in fluorospecialties and specialty polyamides. The mix development and introduction of high-value new business have been favorable, although pricing itself was rather neutral. Q: Can you clarify the expected contribution from big projects starting up this year, and when did the slowdown in Adhesive Technologies begin? A: Thierry Le Henaff, CEO: We expect at least EUR 80 million contribution from projects, more heavily weighted to the second half. The slowdown in Adhesive Technologies began atypically, with significant destocking by customers, particularly in the US and Europe. Q: What is your current sensitivity to FX changes, and how do you expect fluorogases to perform in the second half of the year? A: Thierry Le Henaff, CEO: Our sensitivity to US dollar and euro parity is EUR 50 million for a 10% change. We expect fluorogases to improve in the second half due to low customer stock levels and seasonal demand increases. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. View Comments
Arkema SA (ARKAF) Q1 2025 Earnings Call Highlights: Resilience Amidst Market Challenges
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...